Navigation Links
University of Georgia researchers show component of mothballs is present in deep-space clouds
Date:9/2/2009

Interstellar clouds, drifting through the unimaginable vastness of space, may be the stuff dreams are made of. But it turns out there's an unexpectedly strange component in those clouds, and it's not dreams butmothballs?

Well, not exactly, but researchers from the University of Georgia have just shown for the first time that one component of clouds emitting unusual infrared light know as the Unidentified Infrared Bands (UIRs) is a gaseous version of naphthalene, the chief component of mothballs back on Earth. The UIRs have been seen by astronomers for more than 30 years, but no one has ever identified what specific molecules cause these patterns.

The discovery that a special kind of naphthalene with a single extra proton is out in space is important to those studying interstellar regions for many reasons. One of the most important is that the UIRs are associated with interstellar dust, and understanding the components of that dust could give clues to the origin of these mysterious voyagers. The new information may also provide insights into stellar lifecycles.

The research, led by Michael Duncan, Regents Professor of Chemistry at UGA, was just published in the Astrophysical Journal. The department of chemistry is part of UGA's Franklin College of Arts and Sciences. Co-authors on the paper were Allen Ricks, a doctoral student in Duncan's lab and Gary Douberly, formerly a postdoctoral associate in Duncan's lab and now an assistant professor in the department of chemistry at UGA.

The work was supported by the National Science Foundation.

"This came about because we found a way in our lab to make protonated naphthalene ions," said Duncan, "and that allowed us to examine its infrared spectrum. It turned out to be a near-perfect match for one of the main features in the UIRs."

That naphthalene is part of the UIRs is not totally unexpected, as it is composed of only hydrogen and carbon. Hydrogen composes b
'/>"/>

Contact: Philiip Lee Williams
phil@franklin.uga.edu
706-542-8501
University of Georgia
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Scientists from University of Hawaii at Manoa find genetic marker
2. Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed
3. Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University
4. University Mall Welcomes New Program Concept in Exercise & Wellness
5. Baylor University Economists Call for Different Tack on Health Care Insurance
6. Simcere Announces Strategic Partnership with Sun Yat-Sen University Cancer Center
7. Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials
8. Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
9. Presidential Towers Donates Apartment to the University of Illinois Medical Center
10. Summer heat increases risk of amniotic fluid level deficiency, Ben-Gurion University study reveals
11. University Hospitals in Cleveland named one of the top 10 hospital systems in United States

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...cent of low-income mothers who participated in a r...trong general feeling of distrust of the opposite ...d not prevent them from entering into a marriage, ...e union was often later described by some of the w... of distrust and insecurity. The results of the st...
(Date:12/2/2009)...h cholesterol and become obese? The same way as pe... , More importantly, according to two new studie...uit flies use the same molecular mechanisms as hum...l and a key form of stored fat that contributes to...y to learn more about the genetic and biological p...
(Date:12/2/2009)..., a leading vendor of Internet-based chronic disea...rsion of its software offering. The new release n... and weight management capabilities in addition to... Acton, MA. (PRWEB) December...Internet-based chronic disease management software...
(Date:12/2/2009)...ire-FirstCall/ -- US Farms, Inc. (Pink Sheets: USF... Wellness products, is pleased to announce it will...k,sware A,faire in Oakland, Calif., at the Oakland... information, contact US Farms, Inc. Customer Serv...okswareafaire.com ,, Victor Brandstetter, US F...
(Date:12/2/2009)...Dec. 3 ,, Head of Army,s Warrior Transition C...d Warriors; Army Embraces Reality of ,Unseen Injur... 2 The following was re...ility: ,, WHAT: Wounded veterans and career c...ram,s National Organization on Disability,s Career...
Breaking Medicine News(10 mins):Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2
...st cancer have warned others to be wary of the mam... given a clean diagnosis in spite of having cancer...ast, Phillipa Naismith, 52, and Sandra Harley, 48,...lia's top litigation firms, Maurice Blackburn Cash...
...nfirmed that their studies on bacteria that bunch ...ad and persistent ear infections// that irritate k...s against these conditions is pointless. Oti...ne. It was explained that some are cases of acute ...
...e University of Texas, Southwestern Medical Center...he necessity of a caesarean section //in pregnant ...e UT Southwestern study is the first large-scale c...s in this month's issue of the journal Obstetrics ...
...e leading developmental disability. Statistics sho...r from autism. In US there is a 10-17% increase in...sease has been studied widely and its symptoms kno...an of the Department of Cognitive and Neural Syste...
...ces, differences in the treatment given to male an...blems persist, a new study has found//. In a...en to benefit from hospitals' quality-improvement ...ttack survivors live longer and healthier lives. ...
...fers from Hodgkin's disease, a cancer of the lymph...t on his neck that turned out to be a swollen lymp...led that he also had a tumor near his windpipe. Th...e cancer cells. After two months active cancer cel...
Other Medicine News:Health News:BreastScreen Australia Is Being Sued Towards Medical Negligence 2Health News:‘Biofilms’-Clumped Bacterial Slime Cause Ear Infecti 2Health News:Valtrex Prevents the Need for C-Section among Women Infected With Genital Herpes 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 3Health News:Heart Attack Care Continues To Be Biased In Favor Of Men 2Health News:Heart Attack Care Continues To Be Biased In Favor Of Men 3Health News:US Boy Wants the Right of Choice of Treatment 2
(Date:12/2/2009)...c. 2 Novartis announced today that...on Tasigna® (nilotinib) 200 mg capsules in a ...strength of the company,s hematology portfolio in ...a, at the 51st American Society of Hematology (ASH...pany,s current therapies and investigational agent...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Medical Oxygen Systems - Global Market Op...0164334/Medical-Oxygen-Systems---Global-Market-Opp...stems market for home healthcare setting is reckon...wth expectations stem from demographic factors suc...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Molecular Diagnostics - A World Market Rev...olecular-Diagnostics---A-World-Market-Review.html ...n by several growth factors that include the need ... combine optimized sample preparation, analysis, a...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 1OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 1Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 3Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 1Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 2Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 3
...J., Oct. 29 Sanofi-aventis,announced today that t...d,Apidra(R) (insulin glulisine [rDNA origin] injec...ears and older) with diabetes mellitus., The appr...FDA review of,a 26-week, phase III, open-label, ac... insulin lispro, in 572 children and adolescents (...
..., Oct. 29 CuraGen Corporation,(Nasdaq: CRGN ), a...on,oncology, announced today that Company executiv...t 11:00 a.m. ET on Monday, November 3, 2008,follow...sults and to review,preliminary data from CuraGen,...for the treatment of advanced melanoma., Data fro...
Other Medicine Technology:FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 2FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 3FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 4FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 5CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008 2
Shandon Pathcentre Tissue Processor
Shandon Excelsior Tissue Processor
Shandon Grosslab Junior Grossing Workstation
Shandon Hyperclean 2 Fume Handling Station
Medicine Products: